Search Results

4676 - 4700 of 75376
TitleWireDateTime
MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum Globe Newswire 03/31 07:30
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium Globe Newswire 03/31 07:30
Bitget lists edgeX (EDGE) for Spot Trading Globe Newswire 03/31 07:03
OTC Markets Group Includes Overnight Market Data In Per User & Broker-Dealer Enterprise Licensing Globe Newswire 03/31 07:00
GXO Strengthens Its Presence in Switzerland with Opening of Sant’Antonino Site, a Future-Ready Logistics Hub Globe Newswire 03/31 07:00
Aventon Redefines the Modern Commute with its New Level 4 Series Globe Newswire 03/31 07:00
American Shared Hospital Services Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 03/31 07:00
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 Globe Newswire 03/31 07:00
Bitfarms Reports Fiscal Year 2025 Results   Globe Newswire 03/31 07:00
YXT.com Reports Full Year 2025 Unaudited Financial Results Globe Newswire 03/31 07:00
OTC Markets Group Welcomes Norsemont Mining Inc. to OTCQX Globe Newswire 03/31 07:00
Troilus Provides Update on 2026 Exploration Program, Including 40,000m Drill Campaign Globe Newswire 03/31 07:00
CHUCK E. CHEESE INTRODUCES SENSORY SENSITIVE BIRTHDAYS THIS WORLD AUTISM MONTH Globe Newswire 03/31 07:00
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK Globe Newswire 03/31 07:00
Inc. Names Copyleaks to Its 2026 List of the Fastest-Growing Private Companies in the Northeast Globe Newswire 03/31 07:00
Next Hydrogen Solutions Inc. Reports Q4 2025 and Fiscal 2025 Financial Results and Provides an Update on Strategic Initiatives Globe Newswire 03/31 07:00
Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies Globe Newswire 03/31 07:00
FactSet Reports Results for Second Quarter 2026 Globe Newswire 03/31 07:00
Highwire Debuts Highwire Health, Built for the Speed and Stakes of Today’s Healthcare Market Globe Newswire 03/31 07:00
Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live stream Globe Newswire 03/31 07:00
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA Globe Newswire 03/31 07:00
Seyond Releases 2025 Annual Report | Inflection Point Emerges: Multi-Engine Growth Unlocks Unlimited Potential of Physical AI Globe Newswire 03/31 07:00
Atos Advances AI-Ready Digital Transformation with Lumen Network as a Service Globe Newswire 03/31 07:00
Chagee Announces Fourth Quarter and Full Year 2025 Unaudited Financial Results Globe Newswire 03/31 07:00
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders Globe Newswire 03/31 07:00
4676 - 4700 of 75376

News, Photo and Web Search